The Development of a Small Inherently Safe Homogeneous Reactor for the Production of Medical Isotopes

Abstract

The use of radioisotopes for various procedures in the health care industry has become one of the most important practices in medicine. New interest has been found in the use of liquid fueled nuclear reactors to produce these isotopes due to the ease of fuel processing and ability to efficiently use LEU as the fuel source. A version of this reactor is being developed at the Royal Military College of Canada to act as a successor to the SLOWPOKE-2 platform. The thermal hydraulic and transient characteristics of a 20 kWt version are being studied to verify inherent safety abilities.